Anesthetic protection against hepatic injury

Japanese Journal of Anesthesiology

Volumn 55, Issue 5, 2006, Pages 570-578

  Kotake, Yoshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Anesthetics; Ischemia reperfusion; Liver; Preconditioning; Sepsis

Indexed keywords

DESFLURANE; ENFLURANE; HALOTHANE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; LIVER PROTEIN; PROPOFOL; TRIFLUOROACETIC ACID;

ACYLATION; BIOTRANSFORMATION; DRUG EFFECT; HUMAN; ISCHEMIC PRECONDITIONING; LIVER BLOOD FLOW; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; NONHUMAN; REPERFUSION INJURY; REVIEW; RISK FACTOR; SEPSIS;

ANESTHETICS; ANESTHETICS, INTRAVENOUS; ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER CIRCULATION; PROTECTIVE AGENTS; RATS; REPERFUSION INJURY;

EID: 33646763886     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Ray DC, Drummond GB. Halothane hepatitis. Br J Anaesth 1991; 67: 84-99.
2. Njoku D, Laster MJ, Gong DH, Eger EI 2 nd, Reed GF, Martin JL. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997; 84: 173-8.
3. Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996; 74: 223-33.
4. Martin JL, Njoku D. Metabolism and toxicity of modern inhaled anesthetics. In: Miller RD, editor. Miller's anesthesia Vol 1. 6 th. Philadelphia: Elsevier Churchill Livingstone; 2005. 231 -72.
5. Eger EI II. New inhaled anesthetics. Anesthesiology 1994; 80: 906-22.
6. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999; 29: 1617-23.
7. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90: 42-53.
8. Nishiyama T, Fujimoto T, Hanaoka K. A comparison of liver function after hepatectomy in cirrhotic patients between sevoflurane and isoflurane in anesthesia with nitrous oxide and epidural block. Anesth Analg 2004; 98: 990-3.
9. Pasupathy S, Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur J Vasc Endovasc Surg 2005; 29: 106 -15.
10. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30: 1223-31.
11. Schulz R, Walz MK, Behrends M, Neumann T, Gerken G, Heusch G. Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 2001; 280: H 198-207.
12. Arii S, Imamura M. Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury. J Hepatobiliary Pancreat Surg 2000; 7: 40-8.
13. Pannen BH. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 2002; 94: 1448-57.
14. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg 2003; 20: 383-96.
15. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-36.
16. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-62.
17. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-50.
18. Nuzzo G, Giuliante F, Vellone M, De Cosmo G, Ardito F, Murazio M, et al. Pedicle clamping with ischemic preconditioning in liver resection. Liver Transpl 2004; 10: S 53-7.
19. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004; 10: 2580-4.
20. Chouker A, Schachtner T, Schauer R, Dugas M, Lohe F, Martignoni A, et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth 2004; 93: 204-11.
21. Chouker A, Martignoni A, Schauer R, Dugas M, Rau HG, Jauch KW, et al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg 2005; 140: 129-36.
22. Kon S, Imai M, Inaba H. Isoflurane attenuates early neutrophil- independent hypoxia-reoxygenation injuries in the reperfused liver in fasted rats. Anesthesiology 1997; 86: 128-36.
23. Ishida H, Kadota Y, Sameshima T, Nishiyama A, Oda T, Kanmura Y. Comparison between sevoflurane and isoflurane anesthesia in pig hepatic ischemia-reperfusion injury. J Anesth 2002; 16: 44-50.
24. Shimono H, Goromaru T, Kadota Y, Tsurumaru T, Kanmura Y. Propofol displays no protective effect against hypoxia/reoxygenation injury in rat liver slices. Anesth Analg 2003; 97: 442-8.
25. Chen MY, Li CH, Huang ZQ, Liu JC, Zhou NX, Huang XQ, et al. Protective effects of lidocaine injected into the hepatoduodenal ligament on warm ischemia-reperfusion injury to the rat liver. Chin Med J (Engl) 2004; 117: 275-9.
26. Totsuka E, Fung JJ, Urakami A, Moras N, Ishii T, Takahashi K, et al. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 2000; 31: 577-80.
27. Wilson DJ, Fisher A, Das K, Goerlitz F, Holland BK, De La Torre AN, et al. Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 2003; 75: 1683-7.
28. Howard BJ, Pohorecki R, Becker GL, Landers DF. Energy status in anoxic rat hepatocytes: effects of isoflurane, solution composition, and hypothermia. Liver Transpl Surg 1995; 1: 220-4.
29. Kusano T, Shiraishi M, Miyaguni T, Hara J, Muto Y. Organ preserving effect of lidocaine administration in the model of orthotopic liver transplantation from non-heart-beating donors. Transplant Proc 1996; 28: 1928-9.
30. Strassburg CP. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol 2003; 17: 369-81.
31. Tsao CM, Ho ST, Chen A, Wang JJ, Tsai SK, Wu CC. Propofol ameliorates liver dysfunction and inhibits aortic superoxide level in conscious rats with endotoxic shock. Eur J Pharmacol 2003; 477: 183-93.
32. Suliburk JW, Gonzalez EA, Kennison SD, Helmer KS, Mercer DW. Differential effects of anesthetics on endotoxin-induced liver injury. J Trauma 2005; 58: 711-6.
33. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002; 30: 904-7.
34. Gallos G, Jones DR, Nasr SH, Emala CW, Lee HT. Local anesthetics reduce mortality and protect against renal and hepatic dysfunction in murine septic peritonitis. Anesthesiology 2004; 101: 902-11.